Imaging Management of Palpable Breast Abnormalities

被引:43
作者
Lehman, Constance D. [1 ]
Lee, Amie Y. [1 ]
Lee, Christoph I. [1 ]
机构
[1] Univ Washington, Seattle Canc Care Alliance, Dept Radiol, Seattle, WA 98109 USA
关键词
breast; evidence-based medicine; mammography; ultrasound; PROBABLY BENIGN; DIAGNOSTIC MAMMOGRAPHY; TRIPLE TEST; FOLLOW-UP; ULTRASOUND; BIOPSY; MASSES; WOMEN; CANCER; SONOGRAPHY;
D O I
10.2214/AJR.14.12725
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
OBJECTIVE. Women commonly present to imaging departments with a palpable breast abnormality. However, widespread confusion remains regarding the most appropriate sequence and extent of imaging required. The purpose of this article is to discuss the evidence informing current management guidelines for the care of patients with palpable breast abnormalities. CONCLUSION. Ultrasound is a highly effective imaging tool for guiding effective evaluation of women with palpable breast abnormalities and should be used for all women with suspicious findings at clinical breast examination. The exception is cases in which mammography shows a clearly benign correlate or a normal, fatty area of breast tissue in the location of the palpable finding. Breast ultrasound should be the primary imaging tool for women with palpable lumps who are pregnant, lactating, or younger than 30 years. For women 40 years old and older, mammography, followed in most cases by ultrasound, is recommended. For women 30-39 years old, ultrasound or mammography may be performed first at the discretion of the radiologist or referring provider. There is little to no role for breast MRI or other advanced imaging technologies in the routine diagnostic evaluation of palpable breast abnormalities.
引用
收藏
页码:1142 / 1153
页数:12
相关论文
共 55 条
[1]  
Barlow WE, 2002, J NATL CANCER I, V94, P1151
[2]   Does this patient have breast cancer? The screening clinical breast examination: Should it be done? How? [J].
Barton, MB ;
Harris, R ;
Fletcher, SW .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 282 (13) :1270-1280
[3]   Breast symptoms among women enrolled in a health maintenance organization: Frequency, evaluation, and outcome [J].
Barton, MB ;
Elmore, JG ;
Fletcher, SW .
ANNALS OF INTERNAL MEDICINE, 1999, 130 (08) :651-+
[4]  
Bickley L.S., 2013, BATES GUIDE PHYS EXA, V11th
[5]  
Dall BJG, 2008, CLIN RADIOL, V63, P516, DOI 10.1016/j.crad.2007.11.001
[6]   Breast biopsy avoidance: The value of normal mammograms and normal sonograms in the setting of a palpable lump [J].
Dennis, MA ;
Parker, SH ;
Klaus, AJ ;
Stavros, AT ;
Kaske, TI ;
Clark, SB .
RADIOLOGY, 2001, 219 (01) :186-191
[7]  
DONEGAN WL, 1992, NEW ENGL J MED, V327, P937
[8]  
Durfee Sara M., 2000, Breast J, V6, P247, DOI 10.1046/j.1524-4741.2000.99111.x
[9]  
Edney J, 2010, AM J SURG, V200, P717
[10]  
Georgian-Smith D, 2000, J CLIN ULTRASOUND, V28, P211, DOI 10.1002/(SICI)1097-0096(200006)28:5<211::AID-JCU1>3.0.CO